Advertisement

Implications of Genetic Patents on Human Genetic Resources: Issues of Ownership, Benefit Sharing and Informed Consent

Chapter
  • 1.3k Downloads

Abstract

With the increasing commercialization of human genetic research, human genetic material has become a source for patenting. The increased extension of patent rights to human genetic material has serious implications for research subjects and patients whose genetic material is used in the research. The ownership of human genetic material has become a controversial issue as a variety of proprietary rights are claimed over it such as patent rights, personal rights, sovereign rights and academic rights. Among these claims, the ownership rights claims of patients, researchers and research subjects has been contested in courts and started an open debate among legal scholars and policy makers. In genetic research, researchers and sponsors thereof are basically concerned to exploit the human genetic material to earn credit by claiming their exclusive rights. It raises the question, whether may researchers obtain patent rights through observation, isolation and manipulation of the human genetic material, without recognizing and admitting contribution of research subjects and patients who have given their genetic material for the research? The commercial exploitation of human genetic material is not confined to an individual but it also extends to human genetic resources of countries. Trade-Related Aspects of Intellectual Property Rights (TRIPS) does not contain any explicit reference to genetic material, and the laws that restrict access to genetic material to obtain remuneration for the nation such as Convention on Biological Diversity (CBD) exclude human genetic material from their ambit. This has led to a growing exploitation of human genetic resources for scientific or commercial purposes.

Keywords

Ownership of human genetic material Human genome Research subjects and patients Human genetic resources Intellectual property rights Patents TRIPS agreement Convention on biological diversity Non-human genetic resource Sovereign control versus open system Benefit sharing Informed consent 

References

  1. Barnes Mark & Heffernan Kate Gallin (2004) The future uses’ dilemma: secondary uses of data and materials by researchers and commercial research sponsors. Medical Research Law & Policy Report 1: 3Google Scholar
  2. Jasper A. Bovenberg (2006) Property rights in blood gene & data: naturally yours? Martinus Nijhoff Publishers, Lieden, p. 1Google Scholar
  3. Boyle James (2003) Enclosing the genome: what squabbles over genetic patents could teach us. In: F. Scott Kieff (ed.), Perspective on properties of the human genome project. Elsevier Academic Press, London (U.K.) p. 111Google Scholar
  4. Richard A. Epstein (2003) Steady the course: property rights in genetic material. In: F. Scott Kieff (ed.), Perspective on properties of the human genome project. Elsevier Academic Press, London (U.K.) p. 156Google Scholar
  5. Feldman Robin (2011) Whose body is it anyway? Human cells and the strange effects of property and intellectual property law. Stanford Law Review 63:1381Google Scholar
  6. Amy Harmon, Indian tribe wins fight to limit research of its DNA. New York Times, April 21, 2010. http://www.nytimes.com/2010/04/22/us/22dna.html. Accessed 22 May 2011
  7. N. Narayanan, (2010) Patenting of human genetic material v. bioethics: revisiting the case of John Moore v. Regents of the University of California. http://www.ncbi.nlm.nih.gov/pubmed/20432879. Accessed 21 May 2012
  8. “Ownership of biological sample and clinical data II: U.S. Supreme Court denies certiorari in the Catalona decision”, available at www.mwe.com. Accessed 30 May 2012
  9. Patients lose law suit to reclaim their tissues. http://www.whoownsyourbody.org/catalona.html. Accessed 22 May 2012
  10. Research without patient consent available at http://www.whoownsyourbody.org/havasupai.html (visited on 28 May 2012)
  11. Safrin Sabrina (2004) “Hyperownership in a time of biotechnological promise” American Journal of International Law 98: 645–46CrossRefGoogle Scholar
  12. World Health Organization (2002) Genomics and world health, Report of the Advisory Committee on Health Research 142. http://whqlibdoc.who.int/hq/2002/a74580.pdf. Accessed 1 June 2012
  13. World Health Organization (2005) Genetics, genomics and the patenting of DNA—review of potential implications for health in developing countries 33 http://www.who.int/genpmics/FullReport.pdf. Accessed 30 May 2012

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Amity Law SchoolNoidaIndia

Personalised recommendations